[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Europe HER2-negative Breast Cancer Market Report 2016

September 2016 | 129 pages | ID: EF8F4B4398AEN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of HER2-negative Breast Cancer

Revenue, means the sales value of HER2-negative Breast Cancer

This report studies sales (consumption) of HER2-negative Breast Cancer in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
  • Covidien llc (Medtronic)
  • Johnson & Johnson MEDICAL
  • Bolton Surgical
  • Platts & Nisbett
  • Frankenman International
  • Changzhou Waston
  • Jiangsu Qianjing Medical
  • Changzhou Anker Medical
  • Changzhou Tongchuang Medical
  • Jiangsu Reable Medical
  • Changzhou Resource Medical
  • Jiangsu Kangjin Medical
  • Merck Serono
  • Merrimack
  • Nektar
  • Tesaro
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of HER2-negative Breast Cancer in these countries, from 2011 to 2021 (forecast), like
  • Germany
  • France
  • UK
  • Russia
  • Italy
  • Spain
  • Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by application, this report focuses on sales, market share and growth rate of HER2-negative Breast Cancer in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
Europe HER2-negative Breast Cancer Market Report 2016

1 HER2-NEGATIVE BREAST CANCER OVERVIEW

1.1 Product Overview and Scope of HER2-negative Breast Cancer
1.2 Classification of HER2-negative Breast Cancer
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of HER2-negative Breast Cancer
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 HER2-negative Breast Cancer Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of HER2-negative Breast Cancer (2011-2021)
  1.5.1 Europe HER2-negative Breast Cancer Sales and Growth Rate (2011-2021)
  1.5.2 Europe HER2-negative Breast Cancer Revenue and Growth Rate (2011-2021)

2 EUROPE HER2-NEGATIVE BREAST CANCER BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe HER2-negative Breast Cancer Market Competition by Manufacturers
  2.1.1 Europe HER2-negative Breast Cancer Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe HER2-negative Breast Cancer Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe HER2-negative Breast Cancer (Volume and Value) by Type
  2.2.1 Europe HER2-negative Breast Cancer Sales and Market Share by Type (2011-2016)
  2.2.2 Europe HER2-negative Breast Cancer Revenue and Market Share by Type (2011-2016)
2.3 Europe HER2-negative Breast Cancer (Volume and Value) by Countries
  2.3.1 Europe HER2-negative Breast Cancer Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe HER2-negative Breast Cancer Revenue and Market Share by Countries (2011-2016)
2.4 Europe HER2-negative Breast Cancer (Volume) by Application

3 GERMANY HER2-NEGATIVE BREAST CANCER (VOLUME, VALUE AND SALES PRICE)

3.1 Germany HER2-negative Breast Cancer Sales and Value (2011-2016)
  3.1.1 Germany HER2-negative Breast Cancer Sales and Growth Rate (2011-2016)
  3.1.2 Germany HER2-negative Breast Cancer Revenue and Growth Rate (2011-2016)
  3.1.3 Germany HER2-negative Breast Cancer Sales Price Trend (2011-2016)
3.2 Germany HER2-negative Breast Cancer Sales and Market Share by Manufacturers
3.3 Germany HER2-negative Breast Cancer Sales and Market Share by Type
3.4 Germany HER2-negative Breast Cancer Sales and Market Share by Application

4 FRANCE HER2-NEGATIVE BREAST CANCER (VOLUME, VALUE AND SALES PRICE)

4.1 France HER2-negative Breast Cancer Sales and Value (2011-2016)
  4.1.1 France HER2-negative Breast Cancer Sales and Growth Rate (2011-2016)
  4.1.2 France HER2-negative Breast Cancer Revenue and Growth Rate (2011-2016)
  4.1.4 France HER2-negative Breast Cancer Sales Price Trend (2011-2016)
4.2 France HER2-negative Breast Cancer Sales and Market Share by Manufacturers
4.3 France HER2-negative Breast Cancer Sales and Market Share by Type
4.4 France HER2-negative Breast Cancer Sales and Market Share by Application

5 UK HER2-NEGATIVE BREAST CANCER (VOLUME, VALUE AND SALES PRICE)

5.1 UK HER2-negative Breast Cancer Sales and Value (2011-2016)
  5.1.1 UK HER2-negative Breast Cancer Sales and Growth Rate (2011-2016)
  5.1.2 UK HER2-negative Breast Cancer Revenue and Growth Rate (2011-2016)
  5.1.5 UK HER2-negative Breast Cancer Sales Price Trend (2011-2016)
5.2 UK HER2-negative Breast Cancer Sales and Market Share by Manufacturers
5.3 UK HER2-negative Breast Cancer Sales and Market Share by Type
5.4 UK HER2-negative Breast Cancer Sales and Market Share by Application

6 RUSSIA HER2-NEGATIVE BREAST CANCER (VOLUME, VALUE AND SALES PRICE)

6.1 Russia HER2-negative Breast Cancer Sales and Value (2011-2016)
  6.1.1 Russia HER2-negative Breast Cancer Sales and Growth Rate (2011-2016)
  6.1.2 Russia HER2-negative Breast Cancer Revenue and Growth Rate (2011-2016)
  6.1.6 Russia HER2-negative Breast Cancer Sales Price Trend (2011-2016)
6.2 Russia HER2-negative Breast Cancer Sales and Market Share by Manufacturers
6.3 Russia HER2-negative Breast Cancer Sales and Market Share by Type
6.4 Russia HER2-negative Breast Cancer Sales and Market Share by Application

7 ITALY HER2-NEGATIVE BREAST CANCER (VOLUME, VALUE AND SALES PRICE)

7.1 Italy HER2-negative Breast Cancer Sales and Value (2011-2016)
  7.1.1 Italy HER2-negative Breast Cancer Sales and Growth Rate (2011-2016)
  7.1.2 Italy HER2-negative Breast Cancer Revenue and Growth Rate (2011-2016)
  7.1.7 Italy HER2-negative Breast Cancer Sales Price Trend (2011-2016)
7.2 Italy HER2-negative Breast Cancer Sales and Market Share by Manufacturers
7.3 Italy HER2-negative Breast Cancer Sales and Market Share by Type
7.4 Italy HER2-negative Breast Cancer Sales and Market Share by Application

8 SPAIN HER2-NEGATIVE BREAST CANCER (VOLUME, VALUE AND SALES PRICE)

8.1 Spain HER2-negative Breast Cancer Sales and Value (2011-2016)
  8.1.1 Spain HER2-negative Breast Cancer Sales and Growth Rate (2011-2016)
  8.1.2 Spain HER2-negative Breast Cancer Revenue and Growth Rate (2011-2016)
  8.1.8 Spain HER2-negative Breast Cancer Sales Price Trend (2011-2016)
8.2 Spain HER2-negative Breast Cancer Sales and Market Share by Manufacturers
8.3 Spain HER2-negative Breast Cancer Sales and Market Share by Type
8.4 Spain HER2-negative Breast Cancer Sales and Market Share by Application

9 BENELUX HER2-NEGATIVE BREAST CANCER (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux HER2-negative Breast Cancer Sales and Value (2011-2016)
  9.1.1 Benelux HER2-negative Breast Cancer Sales and Growth Rate (2011-2016)
  9.1.2 Benelux HER2-negative Breast Cancer Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux HER2-negative Breast Cancer Sales Price Trend (2011-2016)
9.2 Benelux HER2-negative Breast Cancer Sales and Market Share by Manufacturers
9.3 Benelux HER2-negative Breast Cancer Sales and Market Share by Type
9.4 Benelux HER2-negative Breast Cancer Sales and Market Share by Application

10 EUROPE HER2-NEGATIVE BREAST CANCER MANUFACTURERS ANALYSIS

10.1 Covidien llc (Medtronic)
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 HER2-negative Breast Cancer Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Covidien llc (Medtronic) HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Johnson & Johnson MEDICAL
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 HER2-negative Breast Cancer Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Johnson & Johnson MEDICAL HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Bolton Surgical
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 HER2-negative Breast Cancer Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Bolton Surgical HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Platts & Nisbett
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 HER2-negative Breast Cancer Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Platts & Nisbett HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Frankenman International
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 HER2-negative Breast Cancer Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Frankenman International HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Changzhou Waston
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 HER2-negative Breast Cancer Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Changzhou Waston HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Jiangsu Qianjing Medical
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 HER2-negative Breast Cancer Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Jiangsu Qianjing Medical HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Changzhou Anker Medical
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 HER2-negative Breast Cancer Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 Changzhou Anker Medical HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 Changzhou Tongchuang Medical
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 HER2-negative Breast Cancer Product Type, Application and Specification
    10.9.2.1 Type I
    10.9.2.2 Type II
  10.9.3 Changzhou Tongchuang Medical HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 Jiangsu Reable Medical
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 HER2-negative Breast Cancer Product Type, Application and Specification
    10.10.2.1 Type I
    10.10.2.2 Type II
  10.10.3 Jiangsu Reable Medical HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview
10.11 Changzhou Resource Medical
10.12 Jiangsu Kangjin Medical
10.13 Merck Serono
10.14 Merrimack
10.15 Nektar
10.16 Tesaro

11 HER2-NEGATIVE BREAST CANCER MANUFACTURING COST ANALYSIS

11.1 HER2-negative Breast Cancer Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of HER2-negative Breast Cancer

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 HER2-negative Breast Cancer Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of HER2-negative Breast Cancer Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE HER2-NEGATIVE BREAST CANCER MARKET FORECAST (2016-2021)

14.1 Germany HER2-negative Breast Cancer Sales Forecast (2016-2021)
14.2 France HER2-negative Breast Cancer Sales Forecast (2016-2021)
14.3 UK HER2-negative Breast Cancer Sales Forecast (2016-2021)
14.4 Russia HER2-negative Breast Cancer Sales Forecast (2016-2021)
14.5 Italy HER2-negative Breast Cancer Sales Forecast (2016-2021)
14.6 Spain HER2-negative Breast Cancer Sales Forecast (2016-2021)
14.7 Benelux HER2-negative Breast Cancer Sales Forecast (2016-2021)
14.8 Europe HER2-negative Breast Cancer Sales Forecast by Type (2016-2021)
14.9 Europe HER2-negative Breast Cancer Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of HER2-negative Breast Cancer
Table Classification of HER2-negative Breast Cancer
Figure Europe Sales Market Share of HER2-negative Breast Cancer by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of HER2-negative Breast Cancer
Figure Europe Sales Market Share of HER2-negative Breast Cancer by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany HER2-negative Breast Cancer Revenue and Growth Rate (2011-2021)
Figure France HER2-negative Breast Cancer Revenue and Growth Rate (2011-2021)
Figure UK HER2-negative Breast Cancer Revenue and Growth Rate (2011-2021)
Figure Russia HER2-negative Breast Cancer Revenue and Growth Rate (2011-2021)
Figure Italy HER2-negative Breast Cancer Revenue and Growth Rate (2011-2021)
Figure Spain HER2-negative Breast Cancer Revenue and Growth Rate (2011-2021)
Figure Benelux HER2-negative Breast Cancer Revenue and Growth Rate (2011-2021)
Figure Europe HER2-negative Breast Cancer Sales and Growth Rate (2011-2021)
Figure Europe HER2-negative Breast Cancer Revenue and Growth Rate (2011-2021)
Table Europe HER2-negative Breast Cancer Sales of Key Manufacturers (2015 and 2016)
Table Europe HER2-negative Breast Cancer Sales Share by Manufacturers (2015 and 2016)
Figure 2015 HER2-negative Breast Cancer Sales Share by Manufacturers
Figure 2016 HER2-negative Breast Cancer Sales Share by Manufacturers
Table Europe HER2-negative Breast Cancer Revenue by Manufacturers (2015 and 2016)
Table Europe HER2-negative Breast Cancer Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe HER2-negative Breast Cancer Revenue Share by Manufacturers
Table 2016 Europe HER2-negative Breast Cancer Revenue Share by Manufacturers
Table Europe HER2-negative Breast Cancer Sales and Market Share by Type (2011-2016)
Table Europe HER2-negative Breast Cancer Sales Share by Type (2011-2016)
Figure Sales Market Share of HER2-negative Breast Cancer by Type (2011-2016)
Figure Europe HER2-negative Breast Cancer Sales Growth Rate by Type (2011-2016)
Table Europe HER2-negative Breast Cancer Revenue and Market Share by Type (2011-2016)
Table Europe HER2-negative Breast Cancer Revenue Share by Type (2011-2016)
Figure Revenue Market Share of HER2-negative Breast Cancer by Type (2011-2016)
Figure Europe HER2-negative Breast Cancer Revenue Growth Rate by Type (2011-2016)
Table Europe HER2-negative Breast Cancer Sales and Market Share by Countries (2011-2016)
Table Europe HER2-negative Breast Cancer Sales Share by Countries (2011-2016)
Figure Sales Market Share of HER2-negative Breast Cancer by Countries (2011-2016)
Table Europe HER2-negative Breast Cancer Revenue and Market Share by Countries (2011-2016)
Table Europe HER2-negative Breast Cancer Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of HER2-negative Breast Cancer by Countries (2011-2016)
Table Europe HER2-negative Breast Cancer Sales and Market Share by Application (2011-2016)
Table Europe HER2-negative Breast Cancer Sales Share by Application (2011-2016)
Figure Sales Market Share of HER2-negative Breast Cancer by Application (2011-2016)
Figure Germany HER2-negative Breast Cancer Sales and Growth Rate (2011-2016)
Figure Germany HER2-negative Breast Cancer Revenue and Growth Rate (2011-2016)
Figure Germany HER2-negative Breast Cancer Sales Price Trend (2011-2016)
Table Germany HER2-negative Breast Cancer Sales by Manufacturers (2015 and 2016)
Table Germany HER2-negative Breast Cancer Market Share by Manufacturers (2015 and 2016)
Table Germany HER2-negative Breast Cancer Sales by Type (2015 and 2016)
Table Germany HER2-negative Breast Cancer Market Share by Type (2015 and 2016)
Table Germany HER2-negative Breast Cancer Sales by Application (2015 and 2016)
Table Germany HER2-negative Breast Cancer Market Share by Application (2015 and 2016)
Figure France HER2-negative Breast Cancer Sales and Growth Rate (2011-2016)
Figure France HER2-negative Breast Cancer Revenue and Growth Rate (2011-2016)
Figure France HER2-negative Breast Cancer Sales Price Trend (2011-2016)
Table France HER2-negative Breast Cancer Sales by Manufacturers (2015 and 2016)
Table France HER2-negative Breast Cancer Market Share by Manufacturers (2015 and 2016)
Table France HER2-negative Breast Cancer Sales by Type (2015 and 2016)
Table France HER2-negative Breast Cancer Market Share by Type (2015 and 2016)
Table France HER2-negative Breast Cancer Sales by Application (2015 and 2016)
Table France HER2-negative Breast Cancer Market Share by Application (2015 and 2016)
Figure UK HER2-negative Breast Cancer Sales and Growth Rate (2011-2016)
Figure UK HER2-negative Breast Cancer Revenue and Growth Rate (2011-2016)
Figure UK HER2-negative Breast Cancer Sales Price Trend (2011-2016)
Table UK HER2-negative Breast Cancer Sales by Manufacturers (2015 and 2016)
Table UK HER2-negative Breast Cancer Market Share by Manufacturers (2015 and 2016)
Table UK HER2-negative Breast Cancer Sales by Type (2015 and 2016)
Table UK HER2-negative Breast Cancer Market Share by Type (2015 and 2016)
Table UK HER2-negative Breast Cancer Sales by Application (2015 and 2016)
Table UK HER2-negative Breast Cancer Market Share by Application (2015 and 2016)
Figure Russia HER2-negative Breast Cancer Sales and Growth Rate (2011-2016)
Figure Russia HER2-negative Breast Cancer Revenue and Growth Rate (2011-2016)
Figure Russia HER2-negative Breast Cancer Sales Price Trend (2011-2016)
Table Russia HER2-negative Breast Cancer Sales by Manufacturers (2015 and 2016)
Table Russia HER2-negative Breast Cancer Market Share by Manufacturers (2015 and 2016)
Table Russia HER2-negative Breast Cancer Sales by Type (2015 and 2016)
Table Russia HER2-negative Breast Cancer Market Share by Type (2015 and 2016)
Table Russia HER2-negative Breast Cancer Sales by Application (2015 and 2016)
Table Russia HER2-negative Breast Cancer Market Share by Application (2015 and 2016)
Figure Italy HER2-negative Breast Cancer Sales and Growth Rate (2011-2016)
Figure Italy HER2-negative Breast Cancer Revenue and Growth Rate (2011-2016)
Figure Italy HER2-negative Breast Cancer Sales Price Trend (2011-2016)
Table Italy HER2-negative Breast Cancer Sales by Manufacturers (2015 and 2016)
Table Italy HER2-negative Breast Cancer Market Share by Manufacturers (2015 and 2016)
Table Italy HER2-negative Breast Cancer Sales by Type (2015 and 2016)
Table Italy HER2-negative Breast Cancer Market Share by Type (2015 and 2016)
Table Italy HER2-negative Breast Cancer Sales by Application (2015 and 2016)
Table Italy HER2-negative Breast Cancer Market Share by Application (2015 and 2016)
Figure Spain HER2-negative Breast Cancer Sales and Growth Rate (2011-2016)
Figure Spain HER2-negative Breast Cancer Revenue and Growth Rate (2011-2016)
Figure Spain HER2-negative Breast Cancer Sales Price Trend (2011-2016)
Table Spain HER2-negative Breast Cancer Sales by Manufacturers (2015 and 2016)
Table Spain HER2-negative Breast Cancer Market Share by Manufacturers (2015 and 2016)
Table Spain HER2-negative Breast Cancer Sales by Type (2015 and 2016)
Table Spain HER2-negative Breast Cancer Market Share by Type (2015 and 2016)
Table Spain HER2-negative Breast Cancer Sales by Application (2015 and 2016)
Table Spain HER2-negative Breast Cancer Market Share by Application (2015 and 2016)
Figure Benelux HER2-negative Breast Cancer Sales and Growth Rate (2011-2016)
Figure Benelux HER2-negative Breast Cancer Revenue and Growth Rate (2011-2016)
Figure Benelux HER2-negative Breast Cancer Sales Price Trend (2011-2016)
Table Benelux HER2-negative Breast Cancer Sales by Manufacturers (2015 and 2016)
Table Benelux HER2-negative Breast Cancer Market Share by Manufacturers (2015 and 2016)
Table Benelux HER2-negative Breast Cancer Sales by Type (2015 and 2016)
Table Benelux HER2-negative Breast Cancer Market Share by Type (2015 and 2016)
Table Benelux HER2-negative Breast Cancer Sales by Application (2015 and 2016)
Table Benelux HER2-negative Breast Cancer Market Share by Application (2015 and 2016)
Table HER2-negative Breast Cancer Basic Information List
Table Covidien llc (Medtronic) HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Covidien llc (Medtronic) HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table Johnson & Johnson MEDICAL Basic Information List
Table Johnson & Johnson MEDICAL HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson MEDICAL HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table Bolton Surgical Basic Information List
Table Bolton Surgical HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bolton Surgical HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table Platts & Nisbett Basic Information List
Table Platts & Nisbett HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Platts & Nisbett HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table Frankenman International Basic Information List
Table Frankenman International HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Frankenman International HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table Changzhou Waston Basic Information List
Table Changzhou Waston HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Changzhou Waston HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table Jiangsu Qianjing Medical Basic Information List
Table Jiangsu Qianjing Medical HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Jiangsu Qianjing Medical HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table Changzhou Anker Medical Basic Information List
Table Changzhou Anker Medical HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Changzhou Anker Medical HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table Changzhou Tongchuang Medical Basic Information List
Table Changzhou Tongchuang Medical HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Changzhou Tongchuang Medical HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table Jiangsu Reable Medical Basic Information List
Table Jiangsu Reable Medical HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Jiangsu Reable Medical HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table Changzhou Resource Medical Basic Information List
Table Changzhou Resource Medical HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Changzhou Resource Medical HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table Jiangsu Kangjin Medical Basic Information List
Table Jiangsu Kangjin Medical HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Jiangsu Kangjin Medical HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table Merck Serono Basic Information List
Table Merck Serono HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Serono HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table Merrimack Basic Information List
Table Merrimack HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merrimack HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table Nektar Basic Information List
Table Nektar HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Nektar HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table Tesaro Basic Information List
Table Tesaro HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Tesaro HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of HER2-negative Breast Cancer
Figure Manufacturing Process Analysis of HER2-negative Breast Cancer
Figure HER2-negative Breast Cancer Industrial Chain Analysis
Table Raw Materials Sources of HER2-negative Breast Cancer Major Manufacturers in 2015
Table Major Buyers of HER2-negative Breast Cancer
Table Distributors/Traders List
Figure Germany HER2-negative Breast Cancer Sales and Growth Rate Forecast (2016-2021)
Figure Germany HER2-negative Breast Cancer Revenue and Growth Rate Forecast (2016-2021)
Figure France HER2-negative Breast Cancer Sales and Growth Rate Forecast (2016-2021)
Figure France HER2-negative Breast Cancer Revenue and Growth Rate Forecast (2016-2021)
Figure UK HER2-negative Breast Cancer Sales and Growth Rate Forecast (2016-2021)
Figure UK HER2-negative Breast Cancer Revenue and Growth Rate Forecast (2016-2021)
Figure Russia HER2-negative Breast Cancer Sales and Growth Rate Forecast (2016-2021)
Figure Russia HER2-negative Breast Cancer Revenue and Growth Rate Forecast (2016-2021)
Figure Italy HER2-negative Breast Cancer Sales and Growth Rate Forecast (2016-2021)
Figure Italy HER2-negative Breast Cancer Revenue and Growth Rate Forecast (2016-2021)
Figure Spain HER2-negative Breast Cancer Sales and Growth Rate Forecast (2016-2021)
Figure Spain HER2-negative Breast Cancer Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux HER2-negative Breast Cancer Sales and Growth Rate Forecast (2016-2021)
Figure Benelux HER2-negative Breast Cancer Revenue and Growth Rate Forecast (2016-2021)
Table Europe HER2-negative Breast Cancer Sales Forecast by Type (2016-2021)
Table Europe HER2-negative Breast Cancer Sales Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories